Values First Advisors’s Bicycle Therapeutics BCYC Stock Holding History

Values First Advisors’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,392	Closed	-$50.9K	–	184
2023 Q1	$50.9K	Buy	+2,392	New	+$60K	0.03%	189

Other funds holding BCYC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Values First Advisors's BCYC Position: Q2 2023 in Review

Values First Advisors sold out of Bicycle Therapeutics (BCYC) in Q2 2023, closing a stake of 2,392 shares — an estimated $50.9K sold.

Values First Advisors first reported a position in BCYC in Q1 2023 and held it in 1 quarter. The position peaked at $50.9K in Q1 2023. 85 funds tracked by Wall St. Rank hold BCYC as of Q2 2023.

Values First Advisors reported no remaining Bicycle Therapeutics position as of Q2 2023 after selling out during the quarter.
Values First Advisors sold 2,392 Bicycle Therapeutics shares in Q2 2023, an estimated $50.9K.
Values First Advisors first reported a position in Bicycle Therapeutics in Q1 2023 and held it in 1 quarter.
Values First Advisors's Bicycle Therapeutics position peaked at $50.9K in Q1 2023.
85 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2023.

Based on Values First Advisors's 13F filing for Q2 2023, filed 2 Aug 2023.